DYSLIPIDEMIAS

Clinical trials for DYSLIPIDEMIAS explained in plain language.

Never miss a new study

Get alerted when new DYSLIPIDEMIAS trials appear

Sign up with your email to follow new studies for DYSLIPIDEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 21 Not yet recruiting 3 Not yet finished but already full! 13 Completed 24 Terminated 1

Experimental drug for cholesterol and fatty liver fails to advance

Disease control Terminated

This early-stage trial tested a new drug called LY3885125 in people with high cholesterol (dyslipidemia) and non-alcoholic fatty liver disease (NAFLD). The main goal was to check safety and how the body processes the drug. The study was terminated, meaning it stopped early, so it…

Matched conditions: DYSLIPIDEMIAS

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC

DYSLIPIDEMIAS

Get alerted when new DYSLIPIDEMIAS trials appear

Experimental drug for cholesterol and fatty liver fails to advance